Immunoprotein Diagnostic Testing Market by Technology, by Type and by Application - Global Opportunity Analysis and Industry Forecast, 2016-2023

  • ID: 4227000
  • Report
  • Region: Global
  • 199 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Abcam PLC
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Diasorin
  • Enzo Life Sciences
  • MORE

Immunoprotein Diagnostic Testing Market by Technology (Radioimmunoassay, Immunoturbidity Assay, Chemiluminescence Assay, Immunoprotein Electrophoresis, Enzyme-Based Immunoassay, and Immunofluorescence Assay), by Type (C - reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Prealbumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test, and Free Light Chain Diagnostic Test), and by Application (Autoimmune Disease Testing, Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing, and Toxicology Testing) - Global Opportunity Analysis and Industry Forecast, 2016-2023

Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiovascular, oncology, infectious diseases, and others, as they display an abnormal increase in their concentration when in a diseased state. Increase in incidence & prevalence of chronic diseases, rise in geriatric population, and growth in demand for early diagnostic services drive the market growth. However, complex regulatory framework for immunoprotein diagnostic testing limits the growth. The global immunoprotein diagnostic testing market is accounted for $16,485 million in 2016, and is estimated to reach $27,290 million by 2022, growing at a CAGR of 7.4% during the analysis period (2017-2023).

The market is segmented on the basis of type, application, technology, and geography. By type, the market is categorized into C-reactive protein diagnostic test, complement system protein diagnostic test, prealbumin diagnostic test, haptoglobin diagnostic test, immunoglobulin diagnostic test, free light chain diagnostic test, and others. Applications covered in the study include autoimmune disease testing, infectious disease testing, allergy testing, endocrine testing, oncology testing, toxicology testing, and others. Based on technology, it is classified into radioimmunoassay, immunoturbidity assay, chemiluminescence assay, immunoprotein electrophoresis, enzyme-based immunoassay, immunofluorescence assay, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS:

The study provides an in-depth analysis of the global immunoprotein diagnostic testing market with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis for the period of 2016-2023, which enables stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments facilitates to understand the various products of the market.
Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

KEY MARKET SEGMENT:

By Technology

Radioimmunoassay
Immunoturbidity Assay
Chemiluminescence Assay
Immunoprotein Electrophoresis
Enzyme-Based Immunoassay
Immunofluorescence Assay
Others

By Type

C-reactive Protein Diagnostic Test
Complement System Protein Diagnostic Test
Prealbumin Diagnostic Test
Haptoglobin Diagnostic Test
Immunoglobulin Diagnostic Test
Free Light Chain Diagnostic Test
Others

By Application

Autoimmune Testing
Infectious Disease Testing
Allergy Testing
Endocrine Testing
Oncology Testing
Toxicology Testing
Others

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Others
Asia Pacific
Japan
China
India
Others
LAMEA
Latin America
Middle East
Africa
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Abcam PLC
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Diasorin
  • Enzo Life Sciences
  • MORE
CHAPTER 1. INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2. EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3. MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS

3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry

3.4. TOP PLAYERS POSITIONING, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Increase in geriatric population and surge in incidence and prevalence of chronic diseases
3.5.1.2. Increase in government expenditure in the healthcare sector

3.5.2. Restraint

3.5.2.1. Complex regulatory framework

3.5.3. Opportunity

3.5.3.1. Lucrative opportunities from emerging economies

CHAPTER 4. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. RADIOIMMUNOASSAY

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. IMMUNOTURBIDITY ASSAY

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. CHEMILUMINESCENCE ASSAY

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. IMMUNOPROTEIN ELECTROPHORESIS

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

4.6. ENZYME-BASED IMMUNOASSAY

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast

4.7. IMMUNOFLUORESCENCE ASSAY

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast

4.8. OTHER TECHNOLOGY

4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast

CHAPTER 5. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. C-REACTIVE PROTEIN DIAGNOSTIC TEST

5.2.1. Market size and forecast

5.3. COMPLEMENT SYSTEM PROTEIN DIAGNOSTIC TEST

5.3.1. Market size and forecast

5.4. PREALBUMIN DIAGNOSTIC TEST

5.4.1. Market size and forecast

5.5. HAPTOGLOBIN DIAGNOSTIC TEST

5.5.1. Market size and forecast

5.6. IMMUNOGLOBULIN DIAGNOSTIC TEST

5.6.1. Market size and forecast

5.7. FREE LIGHT CHAIN DIAGNOSTIC TEST

5.7.1. Market size and forecast

5.8. OTHER IMMUNOPROTEIN DIAGNOSTIC TEST

5.8.1. Market size and forecast

CHAPTER 6. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. AUTOIMMUNE TESTING

6.2.1. Market size and forecast

6.3. INFECTIOUS DISEASE TESTING

6.3.1. Market size and forecast

6.4. ALLERGY TESTING

6.4.1. Market size and forecast

6.5. ENDOCRINE DISEASE TESTING

6.5.1. Market size and forecast

6.6. ONCOLOGY TESTING

6.6.1. Market size and forecast

6.7. TOXICOLOGY TESTING

6.7.1. Market size and forecast

6.8. OTHERS

6.8.1. Market size and forecast

CHAPTER 7. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Latin America market size and forecast
7.5.5. Middle East market size and forecast
7.5.6. Africa market size and forecast

CHAPTER 8. COMPANY PROFILES

8.1. ABBOTT LABORATORIES

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. ABCAM PLC

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. BIO-RAD LABORATORIES, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. DANAHER CORPORATION

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segment
8.4.4. Product portfolio
8.4.5. Business performance

8.5. DIASORIN S.P.A

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. ENZO BIOCHEM, INC.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Operating business segments
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. F. HOFFMANN-LA ROCHE AG (ROCHE DIAGNOSTICS)

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. ORTHO CLINICAL DIAGNOSTICS

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments

8.9. SIEMENS AKTIENGESELLSCHAFT

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating segments
8.9.4. Product portfolio
8.9.5. Business performance

8.10. THERMO FISHER SCIENTIFIC INC

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Abcam PLC
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Diasorin
  • Enzo Life Sciences
  • MORE
Immunoprotein Diagnostic Testing Market report, forecasts that the global market was valued at $16,485 million in 2016 and is expected to garner $27,290 million by 2022, registering a CAGR of 7.4% during the forecast period 2017 - 2023. The enzyme-based immunoassay segment held one-third share of the total market in 2016.

Immunoprotein is a protein that possesses immunological activity, which provides immunity against pathogenic organisms or substances. High prevalence of diseases such as cancer, cardiovascular diseases, allergies, urological disorders, and orthopedic diseases majorly drives the market. However, stringent regulatory framework with regards to immunoprotein diagnostic tests is projected to restrain the market growth during the forecast period.

The global immunoprotein diagnostic testing market is segmented based on type, application, technology, and geography. Based on technology, the market is classified into radioimmunoassay, immunoturbidity assay, chemiluminescence assay, immunoprotein electrophoresis, enzyme-based immunoassay, and immunofluorescence assay. The enzyme-based immunoassay segment held the largest share of one-third in 2016, owing to wide application of enzyme-based immunoassay.

The immunoglobulin diagnostic test segment held the largest share in 2016, owing to the high adoption of immunoglobulin diagnostic test for the detection of excess or deficiency of immunoglobulins that provides information about the functioning of the immune system.

The infectious disease segment dominated the market in 2016, owing to the high incidence of infectious diseases and hence high usage of immunoprotein diagnostic testing for the detection of infectious diseases.

North America accounted for around two-fifths of the share in 2016, and is expected to dominate the market throughout the forecast period. This is attributed to increase in incidence of diseases due to rise in geriatric population, well-established healthcare systems, and increase in awareness among the population toward timely diagnosis of diseases. In addition, higher adoption rate for technologically advanced devices is anticipated to provide new growth opportunities for the key players in the market. However, Asia-Pacific is projected to grow at the highest during the analysis period, owing to rise in healthcare expenditure, increase in per capita income, growth in demand for healthcare services from large pool of patient population, and improvement in healthcare infrastructure.

Key Findings of Immunoprotein Diagnostic Testing Market

By type, the immunoglobulin diagnostic tests segment dominated the market in 2016, and is projected to grow at the highest CAGR.
By application, the infectious disease testing segment accounted for the highest share of two-sevenths in 2016.
The U.S. was the major shareholder in the North America immunoprotein diagnostic testing market, accounting for seven-eighths share in 2016.
Asia-Pacific is expected to show the highest growth rate during the analysis period.
China is expected to grow at the highest CAGR in the Asia-Pacific immunoprotein diagnostic testing market.
The major players profiled in the global cancer immunotherapy market are Abbott Laboratories, Abcam PLC, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Enzo Life Sciences, Ortho Clinical Diagnostics, Roche Diagnostics, Siemens Healthcare, and Thermo Fisher Scientific.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • Abcam PLC
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Diasorin
  • Enzo Life Sciences
  • Ortho Clinical Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll